Index inclusion creates immediate buying pressure as passive funds purchase shares to match the S&P 500 composition.

Anthem Biosciences IPO listing date is today. Ahead of the listing, Anthem Biosciences IPO GMP today and analysts signal a ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $103.0, a high estimate of $130.00, and a low estimate of $82.00. A decline of 14.7 ...

Indian stock market benchmarks—the Sensex and the Nifty 50—ended lower on Friday, 18 July, extending losses for the third ...